|
2023
|
Invention
|
Synergistic bioactive composition for enhancing activity of pink1/parkin pathway. The present inv... |
|
|
Invention
|
Synergistic composition for modulating expression of cd38. The invention disclosed herein relates... |
|
|
Invention
|
Synergistic composition for improving hypothalamic pituitary gonadal (hpg) axis activity. The pre... |
|
|
Invention
|
Synergistic bioactive composition for modulating choline dehydrogenase (chd) activity. (MTHFR)(MT... |
|
|
Invention
|
Synergistic compositions for enhancing tfeb-mediated intracellular clearance.
Compositions for e... |
|
|
Invention
|
Synergistic compositions for enhancing tfeb-mediated intracellular clearance. The present inventi... |
|
2022
|
Invention
|
Oral algal oil based gastro-intestinal tract permeable peptide composition.
The invention disclo... |
|
|
Invention
|
Oral algal oil based gastro-intestinal tract permeable peptide composition. The invention disclos... |
|
|
Invention
|
A synergistic composition for inhibiting vascular calcification.
The invention disclosed herein ... |
|
|
Invention
|
A synergistic composition for inhibiting vascular calcification. The invention disclosed herein r... |
|
|
Invention
|
A synergistic composition for activating intracellular secondary messenger(camp) pathway. The inv... |
|
|
Invention
|
Synergistic composition for activating intracellular secondary messenger(camp) pathway. The inven... |
|
|
P/S
|
Arranging and conducting online workshops in the field of wellness; Educational and entertainment... |
|
|
Invention
|
A synergistic composition for potentiating stabilized atp. The present invention disclosed herein... |
|
|
Invention
|
Synergistic composition for potentiating stabilized atp. The present invention disclosed herein r... |
|
|
Invention
|
Synergistic nutritional compositions for treating vestibular associated neurodegenerative disease... |
|
|
Invention
|
Synergistic nutritional compositions for treating neurocognitive disorders. The invention disclos... |
|
2021
|
Invention
|
Synergistic nutritional compositions for promoting axonal regeneration. The invention disclosed h... |
|
|
Invention
|
Novel synergistic nutritional compositions for promoting axonal regeneration. The invention discl... |
|
|
Invention
|
Synergistic medicinal compositions for treating dysfunctional d-serine signaling. +/2+Bz) as d-am... |
|
|
Invention
|
Novel synergistic medicinal compositions for treating dysfunctional d-serine signaling. The inven... |
|
|
Invention
|
Synergistic nutritional compositions for treating seizures and chronic inflammatory diseases. The... |
|
|
Invention
|
Novel synergistic nutritional compositions for treating seizures and chronic inflammatory disease... |
|
|
P/S
|
Biological preparations for use in industry and science; Chemicals for use in industry and scienc... |
|
|
Invention
|
Synergistic nutritional compositions for enhancing atp efficiency. The invention disclosed herein... |
|
2020
|
Invention
|
Synergistic nutritional neuroprotective compositions for ameliorating neural dysfunction. The pre... |
|
|
Invention
|
Synergistic nutritional compositions for treating cerebrovascular diseases. The present invention... |
|
|
Invention
|
Synergistic bioactive compositions for treating neurological disorders. The present invention dis... |
|
|
Invention
|
Synergistic lipid controlling compositions. The invention disclosed herein relates to synergistic... |
|
|
Invention
|
Synergistic bioactive compositions for enhancing cellular energy. The present invention relates t... |
|
|
Invention
|
Method of treating endothelial dysfunction. 1-methyl nicotinamide chloride and nitrate of standar... |
|
|
Invention
|
Potent synergistic compositions of vasoactive mediators enhancers for improving vascular endothel... |
|
2019
|
Invention
|
Synergistic nutritional compositions for pain management. The present invention discloses a syner... |
|
|
Invention
|
Synergistic compositions of bioactive agents for optimizing cellular health. The present inventio... |
|
|
Invention
|
Novel synergistic composition comprising sirt1 and ampk activators for treating metabolic syndrom... |
